(Q36311178)

13 August 2017

1 reference

title

Can fatal asthma be prevented?--a personal view (English)

1 reference

13 August 2017

0 references

Serafini U

1

1 reference

13 August 2017

publication date

1 May 1992

1 reference

Clinical & Experimental Allergy

13 August 2017

published in

1 reference

13 August 2017

volume

22

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

576-588

1 reference

Asthma mortality: what have we learned?

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Late-phase reactions: observations on pathogenesis and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Eosinophils and T-lymphocytes in late-phase allergic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

21 January 2018

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

The eosinophil and bronchial asthma: current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Paradoxical bronchospasm associated with the use of inhaled beta agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Identification of the fatality-prone subject with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Asthma mortality and physician competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

The assessment and treatment of asthma: a conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

21 January 2018

Therapy of acute asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Use of corticosteroids in treatment of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Inhaled corticosteroids--their present and future role in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

High-dose inhaled steroid therapy for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Dust mite allergens and asthma—A worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

The presence or absence of bronchial mucus in fatal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Cellular events in the bronchi in mild asthma and after bronchial provocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Bronchoalveolar lavage and asthma: sampling the humors speeds up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Historical perspectives: the epidemic of asthma deaths in the United Kingdom in the 1960s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Fatal asthma--is treatment incriminated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Concomitant use of beta adrenergic agonists and methylxanthines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Toxicity of aerosol propellants in the respiratory and circulatory systems. IX. Summary of the most toxic: trichlorofluormethane (FC 11)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Patients at risk for dying of asthma: New Zealand experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Sudden asphyxic asthma: a distinct entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Asthma--what are the important experiments? State of the art/conference summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Assessment and management of severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Sinusitis and bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Reduction of bronchial hyperreactivity during prolonged allergen avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

Suppression of late-phase skin reactions by immunotherapy with ragweed extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00168.X

10.1111/J.1365-2222.1992.TB00168.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference